Pajson Agro India Gets BSE Nod to Raise Funds Through IPO

On November 20, 2025, Pajson Agro India announced it received BSE's in-principle approval to raise ₹57 crore via an SME initial public offering. As per the draft red herring prospectus (DRHP), the issue consists of a fresh issuance of over 63.09 lakh equity shares with a face value of ₹10 each.  

The proceeds will be directed toward setting up a 2nd cashew nut processing facility in Vizianagaram, Andhra Pradesh, and meeting general corporate objectives. 

Pajson Agro India FY25 Financial Performance 

For the financial year 2024-25 (FY25), Pajson Agro India reported a revenue of ₹187.26 crore and profit after tax of ₹20.42 crore. 

The company has appointed Smart Horizon Capital Advisors Pvt Ltd as the sole book-running lead manager and Bigshare Services as the IPO registrar. With all regulatory steps underway, the company is gearing up for a successful market debut in the SME segment. 

Company Overview and Product Offerings 

Established in 2021, Pajson Agro India is involved in processing raw cashew nuts into kernels for both domestic and global consumption. The company offers multiple cashew grades and also markets select dry fruits under its brand "Royal Mewa."  

Its distribution strategy comprises e-commerce platforms as well as physical retail networks. Pajson supplies its products to well-known clients including Reliance Retail, Haldiram, More Retail, Farmley, Nutraj and Bikanervala. 

Read More: NSE, OYO, Flipkart, and Others: India’s IPO Market is Set for a Landmark Year in 2026! 

Conclusion 

Pajson Agro India's ₹57 crore IPO represents a strategic move to scale operations and strengthen its cashew processing capabilities. With solid FY25 performance and a growing customer base including major retailers, the company is positioning itself for long-term growth through this public issue. 

Disclaimer: This blog has been written exclusively for educational purposes. The securities or companies mentioned are only examples and not recommendations. This does not constitute a personal recommendation or investment advice. It does not aim to influence any individual or entity to make investment decisions. Recipients should conduct their own research and assessments to form an independent opinion about investment decisions. 

Investments in the securities market are subject to market risks, read all the related documents carefully before investing.